Compare Inovio Pharmaceuticals Inc (INO) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Lufax Holding Ltd — how do they compare? Inovio Pharmaceuticals Inc trades at $0.73 (market cap $78.55M), while Lufax Holding Ltd trades at $1.56 (market cap $2.41B). The key difference: Lufax Holding Ltd is far larger — about 30.7× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | LU | |
|---|---|---|
Market Cap | $78.55M | $2.41B |
Sector | Health | Technology |
52-Week High | $2.87 | $4.40 |
52-Week Low | $0.66 | $1.23 |
Enterprise Value | $49.56M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
